RISK SOLUTIONS
Legacy liabilities
What has led epidemiological mesothelioma incidence curves to underestimate asbestos claim decay? We explore the issue and discuss actuarial methods for predicting future costs.
The (re)insurance industry faces a growing wave of challenges—cyber threats, geopolitical tensions, inflation—and a significant emerging risk of per- and polyfluoroalkyl substances (PFAS).
Understanding the complexity and time involved in the federal black lung adjudication process is an imperative for proper claim handling.
By leveraging advanced modeling techniques and continuously updating key actuarial assumptions, the estimation of PFAS liabilities can be improved in real time as this emerging risk evolves.
In a Q&A with Financier Worldwide Magazine, we discuss the evolving litigation of PFAS and the difficulty facing insurers in analysing coverage issues.
While much is still unknown about the impact of PFAS on insurance liabilities, there is likely enough information to develop strategies to estimate reserves.
One in 10 underground coal miners who worked for at least 25 years have black lung disease, according to National Institute for Occupational Safety and Health.
The unusual liabilities of black lung require actuarial and case reserving models that are truly unique.
Black lung disease presents a significant, long-term liability exposure for coal companies, risk pools, and governments, as Milliman consultants Christine Fleming and Travis Grulkowski discuss in this episode of Critical Point.
The COVID-19 pandemic is raising many questions regarding what is a compensable workers’ compensation claim.